Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia. The gene discussed is GP6; the disease is autoimmune thrombocytopenic purpura.